Literature DB >> 10050873

Re: Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

J F Dorgan, C Longcope, F Z Stanczyk, H E Stephenson, R N Hoover.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10050873     DOI： 10.1093/jnci/91.4.380

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Aromatase inhibitors and inactivators for breast cancer therapy.

Authors:  Per E Lønning
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

2.  Genetic variants in hypothalamic-pituitary-adrenal axis genes and breast cancer risk in Caucasians and African Americans.

Authors:  Hongmei Nan; Joanne F Dorgan; Timothy R Rebbeck
Journal:  Int J Mol Epidemiol Genet       Date:  2015-09-09

3.  Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo.

Authors:  Young H Ju; Daniel R Doerge; Kellie A Woodling; James A Hartman; Jieun Kwak; William G Helferich
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

Review 4.  The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum.

Authors:  P E Lønning
Journal:  Ann Oncol       Date:  2010-07-08       Impact factor: 32.976

5.  Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.

Authors:  Edward R Sauter; David S Tichansky; Inna Chervoneva; Eleftherios P Diamandis
Journal:  Environ Health Perspect       Date:  2002-03       Impact factor: 9.031
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.